Macrovascular Complications in Patients with Diabetes and Prediabetes

Dou Huang, Marwan Refaat, Kamel Mohammedi, Amin Jayyousi, Jassim Al Suwaidi, Charbel Abi Khalil

Research output: Contribution to journalReview article

23 Citations (Scopus)

Abstract

Diabetes is a significant health problem worldwide, and its association with cardiovascular disease (CVD) was reported in several studies. Hyperglycemia and insulin resistance seen in diabetes and prediabetes lead to an increase in reactive oxygen species, which triggers intracellular molecular signaling. The resulting prothrombotic state and increase in inflammatory mediators expedite atherosclerotic changes and the development of macrovascular complications. Individuals with diabetes or prediabetes have a higher risk of developing myocardial infarction, stroke, and peripheral artery disease. However, no significant difference in cardiovascular morbidity has been observed with tight glycemic control despite a reduction in some CVD outcomes, and the risk of adverse outcomes such as hypoglycemia was increased. Recently, some GLP-1 receptor agonists and SGLT-2 inhibitors have been shown to reduce cardiovascular events and mortality. In this review we give an overview of the risk and pathogenesis of cardiovascular disease among diabetic and prediabetic patients, as well as the implication of recent changes in diabetes management.

Original languageEnglish
Article number7839101
JournalBioMed Research International
Volume2017
DOIs
Publication statusPublished - 1 Jan 2017

Fingerprint

Prediabetic State
Medical problems
Cardiovascular Diseases
Peripheral Arterial Disease
Hypoglycemia
Hyperglycemia
Insulin Resistance
Reactive Oxygen Species
Stroke
Myocardial Infarction
Morbidity
Mortality
Association reactions
Insulin

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Macrovascular Complications in Patients with Diabetes and Prediabetes. / Huang, Dou; Refaat, Marwan; Mohammedi, Kamel; Jayyousi, Amin; Al Suwaidi, Jassim; Abi Khalil, Charbel.

In: BioMed Research International, Vol. 2017, 7839101, 01.01.2017.

Research output: Contribution to journalReview article

Huang, Dou ; Refaat, Marwan ; Mohammedi, Kamel ; Jayyousi, Amin ; Al Suwaidi, Jassim ; Abi Khalil, Charbel. / Macrovascular Complications in Patients with Diabetes and Prediabetes. In: BioMed Research International. 2017 ; Vol. 2017.
@article{48405e7d7fc5472cae7b74b7f4db9e35,
title = "Macrovascular Complications in Patients with Diabetes and Prediabetes",
abstract = "Diabetes is a significant health problem worldwide, and its association with cardiovascular disease (CVD) was reported in several studies. Hyperglycemia and insulin resistance seen in diabetes and prediabetes lead to an increase in reactive oxygen species, which triggers intracellular molecular signaling. The resulting prothrombotic state and increase in inflammatory mediators expedite atherosclerotic changes and the development of macrovascular complications. Individuals with diabetes or prediabetes have a higher risk of developing myocardial infarction, stroke, and peripheral artery disease. However, no significant difference in cardiovascular morbidity has been observed with tight glycemic control despite a reduction in some CVD outcomes, and the risk of adverse outcomes such as hypoglycemia was increased. Recently, some GLP-1 receptor agonists and SGLT-2 inhibitors have been shown to reduce cardiovascular events and mortality. In this review we give an overview of the risk and pathogenesis of cardiovascular disease among diabetic and prediabetic patients, as well as the implication of recent changes in diabetes management.",
author = "Dou Huang and Marwan Refaat and Kamel Mohammedi and Amin Jayyousi and {Al Suwaidi}, Jassim and {Abi Khalil}, Charbel",
year = "2017",
month = "1",
day = "1",
doi = "10.1155/2017/7839101",
language = "English",
volume = "2017",
journal = "BioMed Research International",
issn = "2314-6133",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Macrovascular Complications in Patients with Diabetes and Prediabetes

AU - Huang, Dou

AU - Refaat, Marwan

AU - Mohammedi, Kamel

AU - Jayyousi, Amin

AU - Al Suwaidi, Jassim

AU - Abi Khalil, Charbel

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Diabetes is a significant health problem worldwide, and its association with cardiovascular disease (CVD) was reported in several studies. Hyperglycemia and insulin resistance seen in diabetes and prediabetes lead to an increase in reactive oxygen species, which triggers intracellular molecular signaling. The resulting prothrombotic state and increase in inflammatory mediators expedite atherosclerotic changes and the development of macrovascular complications. Individuals with diabetes or prediabetes have a higher risk of developing myocardial infarction, stroke, and peripheral artery disease. However, no significant difference in cardiovascular morbidity has been observed with tight glycemic control despite a reduction in some CVD outcomes, and the risk of adverse outcomes such as hypoglycemia was increased. Recently, some GLP-1 receptor agonists and SGLT-2 inhibitors have been shown to reduce cardiovascular events and mortality. In this review we give an overview of the risk and pathogenesis of cardiovascular disease among diabetic and prediabetic patients, as well as the implication of recent changes in diabetes management.

AB - Diabetes is a significant health problem worldwide, and its association with cardiovascular disease (CVD) was reported in several studies. Hyperglycemia and insulin resistance seen in diabetes and prediabetes lead to an increase in reactive oxygen species, which triggers intracellular molecular signaling. The resulting prothrombotic state and increase in inflammatory mediators expedite atherosclerotic changes and the development of macrovascular complications. Individuals with diabetes or prediabetes have a higher risk of developing myocardial infarction, stroke, and peripheral artery disease. However, no significant difference in cardiovascular morbidity has been observed with tight glycemic control despite a reduction in some CVD outcomes, and the risk of adverse outcomes such as hypoglycemia was increased. Recently, some GLP-1 receptor agonists and SGLT-2 inhibitors have been shown to reduce cardiovascular events and mortality. In this review we give an overview of the risk and pathogenesis of cardiovascular disease among diabetic and prediabetic patients, as well as the implication of recent changes in diabetes management.

UR - http://www.scopus.com/inward/record.url?scp=85042093226&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042093226&partnerID=8YFLogxK

U2 - 10.1155/2017/7839101

DO - 10.1155/2017/7839101

M3 - Review article

VL - 2017

JO - BioMed Research International

JF - BioMed Research International

SN - 2314-6133

M1 - 7839101

ER -